Date | Source | Headline | |
---|---|---|---|
26th Jan 2006 | 4:38 pm | PRN | Convertible loan update |
19th Jan 2006 | 7:00 am | RNS | Product Development |
19th Dec 2005 | 1:15 pm | PRN | Resignation of a Director |
8th Dec 2005 | 9:02 am | PRN | Director Shareholding |
18th Nov 2005 | 7:00 am | RNS | Conversion of Loan |
8th Nov 2005 | 7:01 am | RNS | Positive Study Data |
3rd Nov 2005 | 7:00 am | RNS | US Army Order |
25th Oct 2005 | 7:01 am | RNS | Clinical Advisory Board |
18th Oct 2005 | 7:01 am | RNS | Interim Results |
14th Oct 2005 | 1:39 pm | PRN | Directorate Change |
26th Sep 2005 | 9:11 am | RNS | Notice of Results |
11th Aug 2005 | 7:02 am | RNS | USD 2 Million Financing |
14th Jul 2005 | 7:00 am | RNS | Additional Listing |
7th Jul 2005 | 7:01 am | RNS | New Veterinary Application |
23rd Jun 2005 | 4:00 pm | RNS | Impact of Review Paper |
17th Jun 2005 | 7:00 am | RNS | Board Appointment |
16th Jun 2005 | 2:57 pm | RNS | AGM Statement |
6th Jun 2005 | 2:38 pm | PRN | Director Shareholding |
1st Jun 2005 | 7:00 am | RNS | Positive Data |
10th May 2005 | 2:20 pm | PRN | Director Shareholding |
9th May 2005 | 7:00 am | RNS | Registration in Brazil |
25th Apr 2005 | 7:00 am | RNS | Appointment of New Director |
15th Apr 2005 | 11:46 am | RNS | Director Shareholding |
13th Apr 2005 | 7:00 am | RNS | Director Share Options Award |
7th Apr 2005 | 7:00 am | RNS | Director Shareholding |
30th Mar 2005 | 7:01 am | RNS | Preliminary Results |
30th Mar 2005 | 7:01 am | RNS | Product Approval in Denmark |
24th Mar 2005 | 7:02 am | RNS | Launch Of Software Upgrade |
23rd Mar 2005 | 10:50 am | PRN | Additional Listing |
21st Mar 2005 | 7:02 am | RNS | Significant Trial Results |
15th Mar 2005 | 7:02 am | RNS | European Approval |
2nd Mar 2005 | 8:19 am | RNS | Change of Financial PR Agency |
14th Feb 2005 | 7:00 am | PRN | Major Clinical Trial |
24th Jan 2005 | 3:25 pm | PRN | Additional Listing |
19th Jan 2005 | 4:16 pm | PRN | Directorate Change |
13th Jan 2005 | 11:28 am | PRN | Additional Listing |
Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.
To access our Live RNS you must confirm you are a private investor by using the button below.